Studies
The CTN+ supports clinical trials to find new ways to prevent, treat and manage HIV and other STBBIs, prioritizing a community-based approach of the highest scientific and ethical standards.
-
CTNPT 035: Vitamin D insufficiency and NAFLD in persons living with HIV
Association of vitamin D insufficiency with non-alcoholic fatty liver disease in HIV mono-infected patients
-
CTN 272: Canadian HIV and Aging cohort
Determinants of Increased Risk of Cardiovascular Diseases in Individuals Living with HIV
-
CTNPT 011: Monitoring penicillin levels for syphilis
Penicillin therapeutic drug monitoring in the treatment of infectious syphilis. Do low serum penicillin concentrations correlate with treatment failure?
-
CTNPT 014: Kaletra®/Celsentri® combination therapy for HIV in the setting of HCV
An observational study of Kaletra®/Celsentri® combination therapy
-
CTNPT 015: COMO cognition study with HIV+ patients
Pilot project to implement a step-wise investigation that includes Cerebrospinal Fluid analysis as a standard of care for HIV+ individuals with cognitive symptoms
-
CTNPT 021: The (BATARI) Pilot Trial
Bone Antiresorptive Therapy with AntiRetroviral Initiation (BATARI) Pilot Trial
-
-
CTN 265: The sexual confidence study
HIV prevention for gay and bisexual men via reduction of social anxiety and substance use in sexual situations
-
CTN 262: Canadian HIV women’s sexual and reproductive health cohort study (CHIWOS)
Canadian HIV women’s sexual and reproductive health cohort study
-
CTN 260: Raltegravir switch study
A randomized prospective open-label study of switching to raltegravir based antiretroviral therapy (ART) compared to maintaining ritonavir boosted protease inhibitor-based ART on liver fibrosis progression in HIV-HCV co-infected individuals
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.
Learn More